The Tn antigen, one of the preferred ligands of MGL, has previously been associated with worse survival [11] and recent research indicates that tumor-specific Tn expression not only promotes tumor cell invasiveness [28], but also alters the immunogenicity of tumor antigens [29]. This evidence concerns the gene CLEC10A and neoplasm.